{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:35:55Z","timestamp":1778618155729,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12350-020-02474-w","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T13:02:38Z","timestamp":1610283758000},"page":"1280-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET\/CT in patients with autonomic dysfunction: feasibility study in IPD patients"],"prefix":"10.1016","volume":"29","author":[{"given":"Harish","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.K.","family":"Deepak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavi","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Shekhar","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02474-w_bib1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease","volume":"115","author":"Bertram","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-020-02474-w_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J Neurochem"},{"key":"10.1007\/s12350-020-02474-w_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s12350-020-02474-w_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.22868","article-title":"The nondeclaration of nonmotor symptoms of Parkinson\u2019s disease to health care professionals: an international study using the nonmotor symptoms questionnaire","volume":"25","author":"Chaudhuri","year":"2010","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1007\/s12350-020-02474-w_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/mds.27268","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: A prospective cohort study","volume":"33","author":"Merola","year":"2018","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1007\/s12350-020-02474-w_bib6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/jnnp-2016-314123","article-title":"\u201cUnder pressure\u201d: is there a link between orthostatic hypotension and cognitive impairment in \u03b1-synucleinopathies?","volume":"87","author":"Udow","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s12350-020-02474-w_bib7","first-page":"71","article-title":"Cardiac sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radiolabeled MIBG","volume":"41","author":"Takatsu","year":"2000","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1007\/s12350-020-02474-w_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1353-8020(01)00052-9","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: a comprehensive symptom survey","volume":"8","author":"Siddiqui","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s12350-020-02474-w_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10286-017-0495-6","article-title":"Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure","volume":"28","author":"Isonaka","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1007\/s12350-020-02474-w_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-009-0596-y","article-title":"Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson\u2019s disease: an anatomical study","volume":"118","author":"Ghebremedhin","year":"2009","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1007\/s12350-020-02474-w_bib11","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1172\/JCI45803","article-title":"Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases","volume":"121","author":"Goldstein","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-020-02474-w_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM199703063361004","article-title":"Sympathetic cardioneuropathy in dysautonomias","volume":"336","author":"Goldstein","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-020-02474-w_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3565(25)33623-2","article-title":"6-Fluorocatecholamines as false adrenergic neurotransmitters","volume":"225","author":"Chiueh","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-020-02474-w_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3565(25)23667-9","article-title":"Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues","volume":"248","author":"Eisenhofer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-020-02474-w_bib15","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1046\/j.1471-4159.1994.63051675.x","article-title":"A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat","volume":"63","author":"Cumming","year":"1994","journal-title":"J Neurochem"},{"key":"10.1007\/s12350-020-02474-w_bib16","first-page":"635","article-title":"PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches","volume":"15","author":"Kumakura","year":"2009","journal-title":"Neurosci Rev J Bringing Neurobiol Neurol Psychiatry"},{"key":"10.1007\/s12350-020-02474-w_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0883-2897(92)90002-G","article-title":"Production of 6-[18F]fluoro-L-dopa and its metabolism in vivo\u2013a critical review","volume":"19","author":"Luxen","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1007\/s12350-020-02474-w_bib18","first-page":"201","article-title":"18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson\u2019s disease","volume":"43","author":"Ceravolo","year":"2002","journal-title":"Synap N Y N"},{"key":"10.1007\/s12350-020-02474-w_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1007\/s12350-020-02474-w_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.10461","article-title":"Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson\u2019s disease","volume":"18","author":"Courbon","year":"2003","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1007\/s12350-020-02474-w_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1148\/radiol.12112723","article-title":"Pattern of cardiac sympathetic denervation in idiopathic parkinson disease studied with 11C hydroxyephedrine PET","volume":"265","author":"Wong","year":"2012","journal-title":"Radiology"},{"key":"10.1007\/s12350-020-02474-w_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2967\/jnumed.116.176891","article-title":"2-Year natural decline of cardiac sympathetic innervation in idiopathic parkinson disease studied with 11C-hydroxyephedrine PET","volume":"58","author":"Wong","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02474-w_bib23","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/0735-1097(93)90786-Z","article-title":"Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans","volume":"22","author":"Goldstein","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02474-w_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00259-009-1202-1","article-title":"Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson\u2019s disease who were diagnosed with dopamine PET","volume":"37","author":"Ishibashi","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02474-w_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.CIR.101.5.516","article-title":"Evaluation of sympathetic nerve terminals with [11C]epinephrine and [11C]hydroxyephedrine and positron emission tomography","volume":"101","author":"M\u00fcnch","year":"2000","journal-title":"Circulation"},{"key":"10.1007\/s12350-020-02474-w_bib26","first-page":"310","article-title":"Physiological changes in human cardiac sympathetic innervation and activity assessed by (123)I-metaiodobenzylguanidine (MIGB) imaging","volume":"73","author":"Sakata","year":"2009","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"10.1007\/s12350-020-02474-w_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202302","article-title":"Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging","author":"Burger","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1007\/s12350-020-02474-w_bib28","first-page":"1227","article-title":"Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma","volume":"43","author":"Eldadah","year":"2004","journal-title":"Hypertens Dallas Tex 1979"},{"key":"10.1007\/s12350-020-02474-w_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9149(86)90908-2","article-title":"Anatomy of human extrinsic cardiac nerves and ganglia","volume":"57","author":"Janes","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-020-02474-w_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1139\/y86-165","article-title":"Functional and anatomical variability of canine cardiac sympathetic efferent pathways: implications for regional denervation of the left ventricle","volume":"64","author":"Janes","year":"1986","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1007\/s12350-020-02474-w_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.10236","article-title":"Progressive loss of cardiac sympathetic innervation in Parkinson\u2019s disease","volume":"52","author":"Li","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1007\/s12350-020-02474-w_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"key":"10.1007\/s12350-020-02474-w_bib33","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbadis.2008.10.003","article-title":"Imaging neurodegeneration in Parkinson\u2019s disease","volume":"1792","author":"Pavese","year":"2009","journal-title":"Biochim Biophys Acta BBA Mol Basis Dis"},{"key":"10.1007\/s12350-020-02474-w_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12149-013-0702-z","article-title":"Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson\u2019s disease","volume":"27","author":"Chiaravalloti","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-020-02474-w_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"Goldstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12350-020-02474-w_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.parkreldis.2017.10.003","article-title":"Cardiac sympathetic denervation predicts PD in at-risk individuals","volume":"52","author":"Goldstein","year":"2018","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02474-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02474-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123003720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123003720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02474-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:12:11Z","timestamp":1761027131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123003720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1071358123003720"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02474-w","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET\/CT in patients with autonomic dysfunction: feasibility study in IPD patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02474-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}